Robert Matthew Lutz serves as Executive at iBio, Inc., where they oversee executive responsibilities. Since joining the company, Robert Matthew Lutz has executed 8 insider transactions totaling $8.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 14, 2025 involved selling 67,760 shares valued at $468.9K.
Robert Matthew Lutz currently holds 293,977 shares of iBio, Inc. (IBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Matthew Lutz has been a net seller of IBIO stock. They have purchased $0 and sold $8.6K worth of shares.
Robert Matthew Lutz's most recent insider trade was on Dec 14, 2025, when they sold 67,760 shares at $6.92 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 24, 2023 | SVRA | $0 | Award | 140,000 | $N/A | Discretionary |
| Nov 11, 2022 | IBIO | $0 | Award | 100,057 | $N/A | Discretionary |
| Mar 10, 2022 | IBIO | $8.6K | Sale | 24,625 | $0.35 | Discretionary |
| Mar 4, 2021 | IBIO | $0 | Award | 232,000 | $N/A | Discretionary |
| Feb 22, 2021 | SBBP | $25.3K | Payment | 6,978 | $3.62 | Discretionary |
| Jan 7, 2021 | SBBP | $0 | Award | 147,500 | $N/A | Discretionary |